CYC share price doubled from re-filing to FDA approval. Was $1.40 on resubmission and $2.80 on FDA approval.
CU6 is valued at double what we are with phase 3 trials.
We have a complete response to the most minor issue on a near FDA approved product, basically de-risked selling in overseas markets already.
Punters looking to sell out this morning are playing a dangerous game.
This will trade up and move towards Euroz 30c price target into approval. Beyond that we are in unknown terrority.
All in my humble opinion. Good luck folks!
Ann: NDA Resubmission Accepted and Approval Date Confirmed, page-27
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.025(8.77%) |
Mkt cap ! $488.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.3¢ | 28.0¢ | $2.622M | 8.854M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 46559 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 989982 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
30.5¢ |
Change
0.025 ( 5.87 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 31.3¢ | 28.0¢ | 4134149 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| BOT (ASX) Chart |